Michael Scolaro

Michael Scolaro

Oct 30, 2017

Group 6 Copy 251
4
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Postpartum Mental Health Needs of Hispanic Mothers

Postpartum mood disorders represent a critical public health issue affecting mothers and their children...

Backer Badge Funded